2022 Annual Meeting | C53 - Child Neurology: Neuromuscular and Movement Disorders

Date Sunday 04/03/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Anne M. Connolly, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology, Movement Disorders, Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives This pediatric neuromuscular and movement disorder course is case based and will introduce six children's stories to answer the question: Where are we now? and Where might we be in 2-3 years? Each child's story will demonstrate the known and emerging understanding of the pathogenesis of the disorder and speakers will examine current and future management options. For appropriate patients, updates on the potential role of gene therapy will also be reviewed. Upon completion, participants will be able to understand the pathogenesis of common and uncommon pediatric neuromuscular and movement disorders and understand the role and status of gene therapy in pediatric neuromuscular and movement disorders.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:10 PM PDT	Speaker	Thinking Outside the Neuromuscle Box...of Age (Part 1) Stefan Nicolau, MD
03:30 PM - 03:30 PM PDT	Speaker	walk in slides Anne M. Connolly, MD, FAAN
04:10 PM - 04:50 PM PDT	Speaker	Pediatric Movement: Too Much? Too Little? Toni Pearson, MBBS
04:50 PM - 05:30 PM PDT	Speaker	Thinking Outside the Neuromuscular Box...of Age (Part 2) Anne M. Connolly, MD, FAAN

Faculty Disclosures
Anne M. Connolly, MD, FAAN	Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Octapharma. Dr. Connolly has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Connolly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Connolly has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Morphic Therapeutics.
Toni Pearson, MBBS	Dr. Pearson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Pearson has received research support from NIH.
Stefan Nicolau, MD	The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation.